Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Abeona Therapeutics Inc. - Common Stock (NQ:ABEO)

5.940 -0.045 (-0.75%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 17, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,095,323
Open	5.860
Bid (Size)	5.850 (1,000)
Ask (Size)	6.250 (100)
Prev. Close	5.985
Today's Range	5.700 - 6.015
52wk Range	4.000 - 7.650
Shares Outstanding	54,191,361
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Abeona Therapeutics Q2 2026 Earnings Call Transcript ↗

August 13, 2026

Abeona Therapeutics (NASDAQ:ABEO) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For...

Via Benzinga

Abeona Therapeutics Q2 Earnings Call Highlights ↗

August 13, 2026

Abeona Therapeutics (NASDAQ:ABEO) reported second-quarter revenue growth from its ZEVASKYN cell therapy launch while outlining operational challenges involving patient scheduling and manufacturing that...

Via MarketBeat

Performance

YTD	+11.9%	+11.9%
1 Month	-8.3%	-8.3%
3 Month	+10.6%	+10.6%
6 Month	+17.9%	+17.9%
1 Year	-14.0%	-14.0%

More News

Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update

August 13, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026

August 06, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics (NASDAQ:ABEO) Reports First Commercial Revenue and Bolstered Balance Sheet in 2025 ↗

March 17, 2026

Via Chartmill

CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®

August 04, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 03, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®

July 21, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 01, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 01, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

May 26, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona (ABEO) Q1 2026 Earnings Transcript ↗

May 13, 2026

Via The Motley Fool

Abeona Therapeutics Q1 Earnings Call Highlights ↗

May 13, 2026

Via MarketBeat

Abeona Reports Strong Q1 Revenue, Expands Treatment Center Network ↗

May 13, 2026

Via Benzinga

Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update

May 13, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics® Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN®

May 11, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics® Announces Date of First Quarter Financial Results

May 04, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 01, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors

April 07, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 06, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York

April 02, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona (ABEO) Q4 2025 Earnings Call Transcript ↗

March 17, 2026

Via The Motley Fool

Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates

March 17, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch

March 09, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference

March 03, 2026

From Abeona Therapeutics Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Abeona Therapeutics Inc. - Common Stock publicly traded?

Yes, Abeona Therapeutics Inc. - Common Stock is publicly traded.

What exchange does Abeona Therapeutics Inc. - Common Stock trade on?

Abeona Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Abeona Therapeutics Inc. - Common Stock?

The ticker symbol for Abeona Therapeutics Inc. - Common Stock is ABEO on the Nasdaq Stock Market

What is the current price of Abeona Therapeutics Inc. - Common Stock?

The current price of Abeona Therapeutics Inc. - Common Stock is 5.940

When was Abeona Therapeutics Inc. - Common Stock last traded?

The last trade of Abeona Therapeutics Inc. - Common Stock was at 08/17/26 04:00 PM ET

What is the market capitalization of Abeona Therapeutics Inc. - Common Stock?

The market capitalization of Abeona Therapeutics Inc. - Common Stock is 321.90M

How many shares of Abeona Therapeutics Inc. - Common Stock are outstanding?

Abeona Therapeutics Inc. - Common Stock has 322M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.